Appraisal of MDCO-157 and Plavix® Pharmacokinetics and Pharmacodynamics in Healthy Volunteers With an Evaluation

PHASE1CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
Pharmacokinetics and Pharmacodynamics in Healthy Volunteers
Interventions
DRUG

MDCO-157

intravenous administration

DRUG

PLAVIX

oral administration

Trial Locations (1)

Unknown

Groupe Hospitalier Pitié-Salpêtrière, Paris

Sponsors
All Listed Sponsors
lead

The Medicines Company

INDUSTRY